objective to determine the effects of the probiotic lactic acid bacterium lactobacillus rhamnosus hn001 on natural cellular immunity when delivered orally in normal lowfat milk lfm or lactosehydrolyzed lowfat milk lfmlhdesign a three stage prepost intervention trial spanning nine weekssetting taipei medical college hospital taipei taiwansubjects fiftytwo healthy middleaged and elderly volunteers 17 males 35 females median age 635 range 4480interventions stage 1 runin diet 25 g200 ml reconstituted lfm powder twice daily for 3 weeksstage 2 probiotic intervention lfm or lfmlh supplemented with 109 cfusg l rhamnosus hn001 in each case for 3 weeksstage 3 washout lfm for 3 weeksmeasures of outcome in vitro phagocytic capacity of peripheral blood polymorphonuclear pmn leukocytes in vitro tumoricidal activity of natural killer nk leukocytesresults immunological responses were unaffected by the runin diet of lfm alonein contrast the relative proportion of pmn cells showing phagocytic activity increased by 19 and 15 respectively following consumption of hn001 in either lfm or lfmlh the relative level of nk cell tumor killing activity increased by 71 and 147in most cases these levels declined following cessation but remained above baselineconclusions dietary consumption of l rhamnosus hn001 in a base of lowfat milk or lactosehydrolyzed lowfat milk appears to enhance systemic cellular immune responses and may be useful as a dietary supplement to boost natural immunity